As the South African Health Products Regulatory Authority (SAHPRA) embarks on the journey outlined in our Strategic Plan for 2025–2030, it is imperative to reaffirm our commitment to ensuring access to safe, effective, and high-quality health products. Guided by our reinforced vision— an agile and...
As the South African Health Products Regulatory Authority (SAHPRA) embarks on the journey outlined in our Annual Performance Plan for 2025–2026, it is imperative to reaffirm our commitment to ensuring access to safe, effective, and high-quality health products. Guided by our reinforced vision— An agile...
This Annual Performance Plan (APP) for the 2024/25 financial year that has been developed by SAHPRA, represents the planned actions of the Board of SAHPRA to ensure that through their considered and responsible actions, they can, together with the staff at the Authority, assure and...
This Annual Performance Plan (APP) for the 2023/24 financial year that has been developed by SAHPRA, represents the planned actions of the Board of SAHPRA to ensure that through their considered and responsible actions, they can, together with the staff at the Authority, assure and...
The South African Health Products Regulatory Authority’s (SAHPRA) Strategic Plan 2020/21 - 2024/25 serves as a guide for the entity to deliver on its core mandate as prescribed in the Medicines and Related Substances Act, 1965 (Act No. 101 of 1965), as amended....
In order to execute its mandate as a health products regulator, the South African Health Products Regulatory Authority (SAHPRA) will engage with stakeholders on an ongoing basis. The stakeholders are individuals and organisations who have an interest in or are influenced by its work and...
The South African Health Products Regulatory Authority’s (SAHPRA) Annual Performance Plan 2020/21, which is based on the 2020/21-2021/25 Strategic Plan serves as a guide for the entity to deliver on its core mandate as prescribed in the Medicines and Related Substances Act, 1965 (Act No....
The South African Health Products Regulatory Authority’s (SAHPRA) Annual Performance Plan 2021/22, which is based on the 2020/21 2024/25 Strategic Plan serves as a guide for the entity to deliver on its core mandate as prescribed in the Medicines and Relate d Substances Act, 1965...
This Annual Performance Plan for the 2022/23 financial year that has been developed by SAHPRA, represents the planned actions of the Board of SAHPRA to ensure that through their considered and responsible actions, they can, together with the staff at the Authority, assure and guide...